EP1490139A2 - Mikrokatheter mit spitzenreliefregion - Google Patents
Mikrokatheter mit spitzenreliefregionInfo
- Publication number
- EP1490139A2 EP1490139A2 EP03721517A EP03721517A EP1490139A2 EP 1490139 A2 EP1490139 A2 EP 1490139A2 EP 03721517 A EP03721517 A EP 03721517A EP 03721517 A EP03721517 A EP 03721517A EP 1490139 A2 EP1490139 A2 EP 1490139A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- microcatheter
- catheter
- relief region
- tip relief
- tip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000009977 dual effect Effects 0.000 claims abstract description 14
- 229910001000 nickel titanium Inorganic materials 0.000 claims abstract description 8
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- -1 polyethylene Polymers 0.000 claims description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- 230000000750 progressive effect Effects 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 229910000990 Ni alloy Inorganic materials 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 229910001260 Pt alloy Inorganic materials 0.000 claims description 2
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 239000000017 hydrogel Substances 0.000 description 13
- 238000000576 coating method Methods 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 9
- 238000011065 in-situ storage Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- 239000003999 initiator Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 208000022211 Arteriovenous Malformations Diseases 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000005744 arteriovenous malformation Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 206010002329 Aneurysm Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/008—Strength or flexibility characteristics of the catheter tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0054—Catheters; Hollow probes characterised by structural features with regions for increasing flexibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0138—Tip steering devices having flexible regions as a result of weakened outer material, e.g. slots, slits, cuts, joints or coils
Definitions
- the invention relates to a microcatheter having a distal tip with flexibility and strength.
- the microcatheter can be used as one catheter in a coaxial dual lumen microcatheter assembly.
- Microcatheters having sufficient flexibility and size for use in small tortuous vessels have been developed.
- dual lumen microcatheters suitable for delivering viscous fluids to neurovascular sites have not been developed.
- Such dual lumen microcatheters would have a number of applications in diagnostic and interventional medicine, such as drug delivery, imaging, treatment of tumors, aneurysms, arteriovenous malformations (ANMs), etc.
- Hydrogels are useful for a number of biomedical applications. Prepolymers that form hydrogels in situ are administered to the body in liquid form, whereupon they transform into the solid hydrogel. In situ forming hydrogels are especially useful for some applications, such as embolotherapy, tissue bulking, and drug delivery. In situ forming hydrogels are of several types. One type of in situ forming hydrogels is made from crosslinking prepolymers. Such prepolymers contain crosslinkable groups that can be crosslinked after administration (in situ) to form the hydrogel. See WO 01/68720 to BioCure, Inc. and U.S. Patent No. 5,410,016 to Hubbell et al. for examples of such prepolymers.
- WO 01/68720 describes a two part prepolymer system used to form a hydrogel in situ.
- Each of the two parts includes one part of a redox couple.
- crosslinking formation of the hydrogel
- a side-by-side dual lumen catheter is used to deliver the prepolymer compositions.
- One lumen delivers the reducing solution and the second lumen delivers the oxidizing solution.
- the prepolymer can be included in one or both of the reducing and oxidizing solutions.
- This catheter works well for many applications.
- a disadvantage of side-by-side dual lumen catheters for use in delivering a viscous fluid is that they are generally restricted in terms of size. They cannot be made below a certain diameter and maintain the needed flexibility to access tortuous or otherwise hard to reach sites, such as, particularly, neurovascular sites- and be able to deliver a viscous fluid.
- Microcatheters are needed to access many neurovascular sites and to provide super selective embolization. However, as discussed above, it has proved very difficult to design and manufacture a suitable dual lumen microcatheter.
- the invention relates to a microcatheter having a distal end with a tip relief region comprising at least one spiral cut, preferably a full thickness cut, and preferably having decreasing pitch towards the distal tip.
- the microcatheter is preferably made of medical grade superelastic nitinol.
- the microcatheter can be used alone or as one catheter in a dual lumen microcatheter assembly. The assembly is formed by inserting the microcatheter of the invention through a larger inner diameter microcatheter to form a coaxial dual lumen catheter assembly.
- Figure 1 is a view of the microcatheter according to the present invention.
- Figure 2 is a view of one embodiment of the tip relief region of the microcatheter according to the present invention.
- Figure 3 is a cross-sectional view of a dual lumen microcatheter assembly including the microcatheter of the present invention.
- Figure 4 is a view of one embodiment of a dual lumen microcatheter assembly including the microcatheter of the present invention.
- “Microcatheter” means a catheter having a distal tip size of about 4 French or smaller.
- “Strength” means both the ability of a catheter to resist fluid pressures applied to the lumen of the catheter without bursting or leaking, and the ability to resist tensile forces without tearing.
- “Flexibility” means the ability of a catheter to bend when a force is applied in a direction other than along an axis of the catheter. The flexibility is inversely related to the amount of force required to deflect the catheter from an initial position.
- the microcatheter 10 is shown in Figure 1 and includes an elongate tubular body 12, a distal portion 14, and a proximal portion 16.
- the distal portion includes a tip relief region 18.
- An adaptor 20 is attached to the proximal tip.
- microcatheter is designed to be used on its own, as a single lumen microcatheter, or in combination with a larger diameter microcatheter to form a coaxial dual lumen microcatheter assembly.
- the microcatheter of the invention is termed the "microcatheter” herein.
- the larger diameter microcatheter is termed the "second catheter” herein. Requirements for the larger diameter catheter can be discerned from the following discussion.
- microcatheter If the microcatheter is to be used as a stand alone microcatheter, its size is important only so far as it should be of an appropriate size to access the area of interest.
- the microcatheter can be as large as about 4 Fr. It should be understood that the microcatheter and the microcatheter assembly can also be made larger than 4 Fr. However, the microcatheter and the assembly have been specifically designed, and the design is particularly advantageous, when used as a microcatheter, i.e. having a diameter of about 4 Fr or smaller. The design is even more advantageous when a microcatheter, or dual lumen microcatheter, below about 2.8 Fr is needed.
- the microcatheter may be as small as about 0.7 Fr.
- the microcatheter is formed from a tube desirably made of a metal, such as platinum, a platinum alloy, a nickel alloy, a titanium alloy, and some types of stainless steel (such as 316L stainless steel). Desirably, a binary nickel titanium alloy (nitinol) is used. Some plastics such as polyimide, polyethylene, polyurethane, and PTFE may be used. The requirements for the fabrication material will depend upon the desired characteristics of the microcatheter, such as flexibility and strength, and the design parameters such as length and diameter. Desirably, medical grade superelastic nitinol is used.
- the distal tip of the microcatheter has a tip relief portion, illustrated in Figure 2. This region is designed to provide flexibility to the distal portion of the microcatheter while maintaining strength.
- the tip relief portion is provided by a region of spiral cuts at the distal tip. Desirably the cuts are full thickness.
- the relief region can be one continuous spiral cut or a plurality of spiral cut regions.
- the spiral cuts desirably have variable pitch (distance between cuts- expressed as cuts per millimeter (C/mm)).
- the microcatheter has progressive pitch towards the distal tip- in other words, the distance between cuts gets smaller towards the distal tip.
- the pitch desirably is between about 0.05 and 0.10 C/mm at the proximal end of the tip relief region and between about 30 and 60 C/mm at the distal tip, desirably between about 0.15 (proximal end ol tip reliel region) and 50 C/mm (distal end of tip relief region).
- the angle of the cuts can vary between about 20° to 89°.
- the total length of the tip relief region is between about 10 mm and 100 cm, desirably between about 1 and 30 cm, more desirably between about 12 and 20 cm, and more desirably between about 12 and 15 cm for neurological applications.
- the length of the tip relief desirably is about the same length as the "floppy" distal segment of the second catheter.
- the length of the microcatheter can vary between about 60 to 200 cm, desirably between about 120 and 180 cm.
- the distal end cut having variable pitch, makes the microcatheter more kink-resistant and extraordinarily flexible (due to the fine pitch at the distal end). Because the proximal end region is not cut, the microcatheter has secure handling and superior pushability, even in tortuous vessels.
- the microcatheter can be made of the same material its entire length, or can be made of joined together segments made of different materials.
- the microcatheter can be coated along its full length if desired to promote lubriciousness and biocompatibility.
- the prior art contains many examples of coatings that can be used as well as methods for coating.
- the tip relief region can be coated to seal the perforations formed by the cuts, if desired.
- a polyurethane elastomer is desirable based on mechanical properties, biocompatibility, and ease of application. Other materials can be used that provide the necessary biocompatibility and mechanical properties.
- an appropriately sized mandrel is placed inside the microcatheter to provide support and void.
- the microcatheter is then immersed into a solvent containing the dispersed coating material.
- Several dip-coat repetitions may be required to provide a leak- free and uniform barrier film.
- the coating may require exposure to elevated temperatures to aid in volatilizing the remaining solvent.
- the mandrel is removed.
- the coating could alternatively be formed by bonding an extruded polymer tube to the microcatheter using solvent bonding techniques or epoxy bonding techniques.
- a preferred method of coating the microcatheter is by shrink wrapping.
- a tubular sleeve is placed over the microcatheter (either just the tip relief region or a larger portion of the microcatheter) and then heated to shrink.
- Any biocompatible heat shrink material can be used. Desirable materials are polyethylene terephthalate (PET), fluorinated ethylene-propylene (FEP), polyester (PE), and polytetrafluoroethylene (PTFE). Appropriate mate ⁇ als can be obtained from many commercial suppliers.
- a shrink ratio of about 0.1- 9:1 is desirable.
- the proximal end of the microcatheter is desirably provided with an adaptor 20, which allows introduction of a liquid through the catheter.
- the adaptor can be a luer lock adaptor which allows attachment of a syringe.
- a medical grade superelastic nitinol tube for example, nitinol BB-grade alloy - 55.8% by wt. nickel / balance titanium - from Memry Corporation
- CNC Computer Numeric Controlled
- the tubing is attached to a machine with a predetermined tubing feed rate.
- a cutting element such as a laser in this example
- the machine is activated to rotate and feed the tubing.
- rotation of the machine screw thread
- the tubing moves axially and rotationally causing the tubing to be cut in a spiral manner by the laser.
- the machine can be set up to cut either a right or left hand spiral.
- the feed and speed rates can also be set to cut continuous or variable pitch spirals, or multizone spiral sections in which each zone has a unique pitch.
- an appropriately sized mandrel can be placed inside the microtube to provide support and improved heat transfer.
- the heat shrinkable tubing is advanced over the desired section of the microcatheter and heated using a heat gun or other thermal source. When cool, the mandrel is removed.
- the microcatheter assembly is formed using the microcatheter described above and a larger diameter catheter (the second catheter), such as an infusion catheter.
- the second catheter can be one that is commercially available, such as a Tracker 18 or FasTracker 325.
- the second catheter should be of appropriate size to access the intended area.
- the microcatheter and the second catheter should be appropriately sized so that the microcatheter can be slidably inserted within the second catheter.
- Figure 3 illustrates the microcatheter assembly cross-sectionally, where 10 is the microcatheter and 30 designates the second catheter.
- the inner diameter of the second catheter is dimensioned with respect to the outside diameter of the microcatheter to provide sufficient clearance to allow a liquid to pass through the second catheter. For a more viscous liquid, the clearance should be greater.
- the microcatheter should move easily within the second catheter in an axial direction.
- the inner diameter of the second catheter is desirably about 0.011 inches larger than the outer diameter of the microcatheter.
- the second catheter is about 2.8 Fr or less and the microcatheter desirably has an inner diameter ranging from about 0.007 to 0.012 inches and an outer diameter ranging from about 0.010 to 0.018 inches.
- FIG. 4 illustrates one embodiment of a microcatheter assembly.
- the assembly 40 includes second catheter 30, which is attached to the manifold 42 at its proximal end via a luer adaptor, for example.
- the manifold 42 includes a syringe adaptor 44 which provides connection (via a luer lock for example) between the interior space of the manifold 42 (which leads into the second catheter) and a syringe (not shown).
- the manifold 42 includes a second adaptor 46 to receive the microcatheter 10.
- This can be a Tuohy-Borst adaptor, through which the microcatheter can be inserted.
- the microcatheter 10 is then pushed through the manifold and into and through the second catheter 30.
- a syringe (not shown) is fastened to the microcatheter 10 for delivery of a solution.
- the two syringes are retained within a syringe holder (not shown) which allows synchronized delivery of the two solutions.
- the manifold would desirably be designed so that the syringes are aligned.
- the system can include a guidewire (not shown).
- a removable mandrel can be used to support the microcatheter during insertion of the microcatheter within the second catheter. It may be useful to provide a stop on the microcatheter to control the depth of its penetration into the second catheter. Use with a two-part prepolymer composition
- the microcatheter assembly can be used to deliver a two part prepolymer system used to form a hydrogel in situ.
- each of the two parts includes one part of a redox couple.
- crosslinking formation of the hydrogel
- Premature mixing of the two parts can lead to unintended, premature formation of the hydrogel (and clogging of the catheter, for example).
- the initiator solution (less viscous) is delivered through the microcatheter lumen and the prepolymer solution (more viscous) is delivered through the second catheter lumen.
- the viscosities of the prepolymer solution and initiator solution can vary and should be appropriate for the size catheter being used.
- a viscosity of about 10 to 200 cps is appropriate.
- a viscosity ranging from about 1 to 40 is appropriate.
- the solution can theoretically be any viscosity so long as it can be transferred through the catheter.
- the initiator solution delivered through the microcatheter 10 does not contact the prepolymer solution delivered through the second catheter 30. It may be desirable to position the microcatheter within the second catheter so that a mixing chamber is formed at the distal tips of the catheters. In other words, it may be desirable to position the microcatheter so that its tip is recessed from the distal tip of the second catheter.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36594602P | 2002-03-19 | 2002-03-19 | |
| US365946P | 2002-03-19 | ||
| US37036102P | 2002-04-05 | 2002-04-05 | |
| US370361P | 2002-04-05 | ||
| PCT/US2003/010084 WO2003080167A2 (en) | 2002-03-19 | 2003-03-19 | Microcatheter having tip relief region |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1490139A2 true EP1490139A2 (de) | 2004-12-29 |
| EP1490139A4 EP1490139A4 (de) | 2010-01-20 |
Family
ID=28457123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03721517A Withdrawn EP1490139A4 (de) | 2002-03-19 | 2003-03-19 | Mikrokatheter mit spitzenreliefregion |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1490139A4 (de) |
| AU (1) | AU2003224823A1 (de) |
| WO (1) | WO2003080167A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007518478A (ja) * | 2003-12-23 | 2007-07-12 | サイティック コーポレーション | 医療行為を実行するために乳管にアクセスするための医療器具およびその使用方法 |
| US20050283179A1 (en) * | 2004-06-17 | 2005-12-22 | Lentz David J | Introducer sheath |
| US20060258987A1 (en) * | 2005-05-10 | 2006-11-16 | Cook Incorporated | Catheter stiffening member |
| US8257314B2 (en) | 2005-11-16 | 2012-09-04 | Cook Medical Technologies Llc | Spiral shaft catheter |
| EP2722068A1 (de) | 2008-04-08 | 2014-04-23 | Karolinska Institutet Innovations AB | Endoluminale medizinische Zugangsvorrichtung |
| US20090318892A1 (en) * | 2008-06-20 | 2009-12-24 | Maria Aboytes | Removable Core Implant Delivery Catheter |
| EP2376142B1 (de) * | 2009-01-12 | 2018-06-20 | Becton, Dickinson and Company | Infusionsset und/oder patch-pumpe mit mindestens einem starren verweilkatheter mit biegsamen eigenschaften und/oder einem anschluss für einen biegsamen katheter |
| WO2012004165A1 (en) | 2010-07-08 | 2012-01-12 | Karolinska Institutet Innovations Ab | Novel endoluminal medical access device |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5437288A (en) * | 1992-09-04 | 1995-08-01 | Mayo Foundation For Medical Education And Research | Flexible catheter guidewire |
| US5843050A (en) * | 1995-11-13 | 1998-12-01 | Micro Therapeutics, Inc. | Microcatheter |
-
2003
- 2003-03-19 EP EP03721517A patent/EP1490139A4/de not_active Withdrawn
- 2003-03-19 WO PCT/US2003/010084 patent/WO2003080167A2/en not_active Ceased
- 2003-03-19 AU AU2003224823A patent/AU2003224823A1/en not_active Abandoned
Non-Patent Citations (2)
| Title |
|---|
| No further relevant documents disclosed * |
| See also references of WO03080167A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003080167A3 (en) | 2004-03-11 |
| WO2003080167A2 (en) | 2003-10-02 |
| AU2003224823A1 (en) | 2003-10-08 |
| EP1490139A4 (de) | 2010-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040147903A1 (en) | Microcatheter having tip relief region | |
| EP1075297B1 (de) | Strömungsgeführter katheter | |
| EP1620159B1 (de) | Ablagekatheter/schleuse mit grossem durchmesser | |
| US10780246B2 (en) | Vascular microcatheter | |
| JP3970341B2 (ja) | 血管カテーテル | |
| US8262607B2 (en) | Liquid embolic composition delivery devices and methods | |
| US12102776B2 (en) | Embolization microcatheter head having slitted pattern | |
| US20110245775A1 (en) | Tapered sheath | |
| NZ262835A (en) | Infusion catheter for placement within a tortuous, small blood vessel | |
| WO1997017998A1 (en) | Microcatheter | |
| US20220062599A1 (en) | Balloon Occlusion Catheter | |
| WO2003080167A2 (en) | Microcatheter having tip relief region | |
| JP2025535451A (ja) | 編組マイクロバルブ閉塞器を有する治療処置用機器 | |
| CN215875924U (zh) | 一种用于递送双组分水凝胶的同轴双腔微导管 | |
| HK40001849A (en) | Embolization microcatheter head having slitted pattern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20041013 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20091222 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100309 |